Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Nucleic Acids Research|February 19, 2019
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complexZhiqun Shang, Jianpeng Yu, Libin Sun, et al.Scientific Reports|April 19, 2025
The role of adherent-to-suspension transition factors in clear cell renal cell carcinoma progression: a comprehensive analysisChenglong Xu, Haotian Wei, Yue Wang, et al.Oncotarget|December 9, 2014
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancerZhiqun Shang, Qiliang Cai, Minghao Zhang, et al.Oncogene|August 18, 2024
Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancerJianpeng Yu, Minghao Zhang, Taipeng Li, et al.Journal of Experimental & Clinical Cancer Research : CR|August 20, 2023
P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPCMingpeng Zhang, Duo Kan, Boya Zhang, et al.Cell Death & Disease|April 24, 2023
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancerYang Li, Shimiao Zhu, Yutong Chen, et al.Oncogene|February 17, 2019
Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancerShimiao Zhu, Hao Tian, Xiaodan Niu, et al.Oncogene|May 4, 2019
Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancerShimiao Zhu, Hao Tian, Xiaodan Niu, et al.Cell Death & Disease|March 27, 2023
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancerShimiao Zhu, Zhao Yang, Zheng Zhang, et al.The Prostate|January 17, 2022
DNA-repair status should be assessed in treatment-emergent neuroendocrine prostate cancer before platinum-based therapyShimiao Zhu, Zheng Zhang, Hui Zhang, et al.Pageof 5